Browse > Article
http://dx.doi.org/10.4014/jmb.2104.04038

Interplay between the Gut Microbiome and Metabolism in Ulcerative Colitis Mice Treated with the Dietary Ingredient Phloretin  

Ren, Jie (School of Basic Medical Sciences, Xinxiang Medical University)
Li, Puze (School of Basic Medical Sciences, Xinxiang Medical University)
Yan, Dong (School of Basic Medical Sciences, Xinxiang Medical University)
Li, Min (School of Basic Medical Sciences, Xinxiang Medical University)
Qi, Jinsong (Department of Interventation, The First Affiliated Hospital of Xinxiang Medical University)
Wang, Mingyong (Henan Key Laboratory of Immunology and Targeted Therapy, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University)
Zhong, Genshen (Henan Key Laboratory of Immunology and Targeted Therapy, Henan Collaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang Medical University)
Wu, Minna (School of Basic Medical Sciences, Xinxiang Medical University)
Publication Information
Journal of Microbiology and Biotechnology / v.31, no.10, 2021 , pp. 1409-1419 More about this Journal
Abstract
A growing number of healthy dietary ingredients in fruits and vegetables have been shown to exhibit diverse biological activities. Phloretin, a dihydrochalcone flavonoid that is abundant in apples and pears, has anti-inflammatory effects on ulcerative colitis (UC) mice. The gut microbiota and metabolism are closely related to each other due to the existence of the food-gut axis in the human colon. To investigate the interplay of faecal metabolites and the microbiota in UC mice after phloretin treatment, phloretin (60 mg/kg) was administered by gavage to ameliorate dextran sulfate sodium (DSS)-induced UC in mice. Gut microbes and faecal metabolite profiles were detected by high-throughput sequencing and liquid chromatography mass spectrometry (LC-MS) analysis, respectively. The correlations between gut microbes and their metabolites were evaluated by Spearman correlation coefficients. The results indicated that phloretin reshaped the disturbed faecal metabolite profile in UC mice and improved the metabolic pathways by balancing the composition of faecal metabolites such as norepinephrine, mesalazine, tyrosine, 5-acetyl-2,4-dimethyloxazole, and 6-acetyl-2,3-dihydro-2-(hydroxymethyl)-4(1H)-pyridinone. Correlation analysis identified the relations between the gut microbes and their metabolites. Proteus was negatively related to many faecal metabolites, such as norepinephrine, L-tyrosine, laccarin, dopamine glucuronide, and 5-acetyl-2,4-dimethyloxazole. The abundance of unidentified Bacteriodales_S24-7_group was positively related to ecgonine, 15-KETE and 6-acetyl-2,3-dihydro-2-(hydroxymethyl)-4(1H)-pyridinone. The abundance of Christensenellaceae_R-7_group was negatively related to the levels of 15-KETE and netilmicin. Stenotrophomonas and 15-KETE were negatively related, while Intestinimonas and alanyl-serine were positively related. In conclusion, phloretin treatment had positive impacts on faecal metabolites in UC mice, and the changes in faecal metabolites were closely related to the gut microbiota.
Keywords
Phloretin; ulcerative colitis; faecal metabolite; gut microbiota;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.   DOI
2 Visconti A, Le Roy CI, Rosa F, Rossi N, Martin TC, Mohney RP, et al. 2019. Interplay between the human gut microbiome and host metabolism. Nat. Commun. 10: 4505.   DOI
3 Dorrestein PC, Mazmanian SK, Knight R. 2014. Finding the missing links among metabolites, microbes, and the host. Immunity 40: 824-832.   DOI
4 Lin SC, Chen MC, Liu S, Callahan VM, Bracci NR, Lehman CW, et al. 2019. Phloretin inhibits Zika virus infection by interfering with cellular glucose utilisation. Int. J. Antimicrob. Agents 54: 80-84.   DOI
5 Matsuoka K, Kobayashi T, Ueno F, Matsui T, Hirai F, Inoue N, et al. 2018. Evidence-based clinical practice guidelines for inflammatory bowel disease. J. Gastroenterol. 53: 305-353.   DOI
6 Ananthakrishnan AN. 2015. Epidemiology and risk factors for IBD. Nat. Rev. Gastroenterol. Hepatol. 12: 205-217.   DOI
7 Rangan P, Choi I, Wei M, Navarrete G, Guen E, Brandhorst S, et al. 2019. Fasting-mimicking diet modulates microbiota and promotes intestinal regeneration to reduce inflammatory bowel disease pathology. Cell Rep. 26: 2704-2719.e6.   DOI
8 Dabke K, Hendrick G, Devkota S. 2019. The gut microbiome and metabolic syndrome. J. Clin. Invest. 129: 4050-4057.   DOI
9 Torres-Fuentes C, Schellekens H, Dinan TG, Cryan JF. 2017. The microbiota-gut-brain axis in obesity. Lancet Gastroenterol. Hepatol. 2: 747-756.   DOI
10 Zhang D, Jin W, Wu R, Li J, Park SA, Tu E, et al. 2019. High glucose intake exacerbates autoimmunity through reactive-oxygenspecies-mediated TGF-β cytokine activation. Immunity 51: 671-681.e5.   DOI
11 Miranda PM, De Palma G, Serkis V, Lu J, Louis-Auguste MP, McCarville JL, et al. 2018. High salt diet exacerbates colitis in mice by decreasing Lactobacillus levels and butyrate production. Microbiome 6: 57.   DOI
12 Valdes AM, Walter J, Segal E, Spector TD. 2018. Role of the gut microbiota in nutrition and health. BMJ 361: k2179.
13 Rooks MG, Garrett WS. 2016. Gut microbiota, metabolites and host immunity. Nat. Rev. Immunol. 16: 341-352.   DOI
14 Agus A, Planchais J, Sokol H. 2018. Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 23: 716-724.   DOI
15 Capuron L, Schroecksnadel S, Feart C, Aubert A, Higueret D, Barberger-Gateau P, et al. 2011. Chronic low-grade inflammation in elderly persons is associated with altered tryptophan and tyrosine metabolism: role in neuropsychiatric symptoms. Biol. Psychiatry 70: 175-182.   DOI
16 Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, et al. 2016. A Dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167: 1339-1353.e21.   DOI
17 Murthy SN, Cooper HS, Shim H, Shah RS, Ibrahim SA, Sedergran DJ. 1993. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig. Dis. Sci. 38: 1722-1734.   DOI
18 Liao X, Song L, Zeng B, Liu B, Qiu Y, Qu H, et al. 2019. Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis. EBioMedicine 44: 665-674.   DOI
19 Sehgal P, Colombel JF, Aboubakr A, Narula N. 2018. Systematic review: safety of mesalazine in ulcerative colitis. Aliment Pharmacol. Ther. 47: 1597-1609.   DOI
20 Baker DE, Kane S. 2004. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis. Rev. Gastroenterol. Disord. 4: 86-91.
21 Podolsky DK. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347: 417-429.   DOI
22 Dahl JU, Gray MJ, Bazopoulou D, Beaufay F, Lempart J, Koenigsknecht MJ, et al. 2017. The anti-inflammatory drug mesalamine targets bacterial polyphosphate accumulation. Nat. Microbiol. 2: 16267.   DOI
23 Garrett WS, Gallini CA, Yatsunenko T, Michaud M, DuBois A, Delaney ML, et al. 2010. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8: 292-300.   DOI
24 Willemze RA, Welting O, van Hamersveld P, Verseijden C, Nijhuis LE, Hilbers FW, et al. 2019. Loss of intestinal sympathetic innervation elicits an innate immune driven colitis. Mol. Med. 25: 1. doi: 10.1186/s10020-018-0068-8.   DOI
25 Kim MH, Kang SG, Park JH, Yanagisawa M, Kim CH. 2013. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 145: 396-406.e1-10.   DOI
26 De Angelis M, Garruti G, Minervini F, Bonfrate L, Portincasa P, Gobbetti M. 2019. The food-gut human axis: the effects of diet on gut microbiota and metabolome. Curr. Med. Chem. 26: 3567-3583.   DOI
27 Agac D, Estrada LD, Maples R, Hooper LV, Farrar JD. 2018. The β2-adrenergic receptor controls inflammation by driving rapid IL-10 secretion. Brain Behav. Immun. 74: 176-185.   DOI
28 Lin HM, Barnett MP, Roy NC, Joyce NI, Zhu S, Armstrong K, et al. 2010. Metabolomic analysis identifies inflammatory and noninflammatory metabolic effects of genetic modification in a mouse model of Crohn's disease. J. Proteome Res. 9: 1965-1975.   DOI
29 Hase A, Jung SE, aan het Rot M. 2015. Behavioral and cognitive effects of tyrosine intake in healthy human adults. Pharmacol. Biochem. Behav. 133: 1-6.   DOI
30 Wu M, Li P, An Y, Ren J, Yan D, Cui J, et al. 2019. Phloretin ameliorates dextran sulfate sodium-induced ulcerative colitis in mice by regulating the gut microbiota. Pharmacol. Res. 150: 104489.   DOI
31 Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. 1990. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98: 694-702.   DOI
32 Yu M, Jia H, Zhou C, Yang Y, Zhao Y, Yang M, et al. 2017. Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics. J. Pharm. Biomed. Anal. 138: 231-239.   DOI
33 Franzosa EA, Sirota-Madi A, Avila-Pacheco J, Fornelos N, Haiser HJ, Reinker S, et al. 2019. Gut microbiome structure and metabolic activity in inflammatory bowel disease. Nat. Microbiol. 4: 293-305.   DOI
34 Alsanea S, Gao M, Liu D. 2017. Phloretin prevents high-fat diet-induced obesity and improves metabolic homeostasis. AAPS J. 19: 797-805.   DOI
35 Dennis PG, Guo K, Imelfort M, Jensen P, Tyson GW, Rabaey K. 2013. Spatial uniformity of microbial diversity in a continuous bioelectrochemical system. Bioresour. Technol. 129: 599-605.   DOI
36 Wang G, Gao Y, Wang H, Wang J, Niu X. 2018. Phloretin reduces cell injury and inflammation mediated by Staphylococcus aureus via targeting sortase B and the molecular mechanism. Appl. Microbiol. Biotechnol. 102: 10665-10674.   DOI
37 Park SY, Kim EJ, Shin HK, Kwon DY, Kim MS, Surh YJ, et al. 2007. Induction of apoptosis in HT-29 colon cancer cells by phloretin. J. Med. Food. 10: 581-586.   DOI
38 Fraga CG, Croft KD, Kennedy DO, Tomas-Barberan FA. 2019. The effects of polyphenols and other bioactives on human health. Food Funct. 10: 514-528.   DOI
39 Del Chierico F, Nobili V, Vernocchi P, Russo A, De Stefanis C, Gnani D, et al. 2017. Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach. Hepatology 65: 451-464.   DOI
40 Nagpal R, Neth BJ, Wang S, Craft S, Yadav H. 2019. Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment. EBioMedicine 47: 529-542.   DOI
41 Okumura R, Kurakawa T, Nakano T, Kayama H, Kinoshita M, Motooka D, et al. 2016. Lypd8 promotes the segregation of flagellated microbiota and colonic epithelia. Nature 532: 117-21.   DOI
42 Wang Q, Wang K, Wu W, Lv L, Bian X, Yang L, et al. 2020. Administration of Bifidobacterium bifidum CGMCC 15068 modulates gut microbiota and metabolome in azoxymethane (AOM)/dextran sulphate sodium (DSS)-induced colitis-associated colon cancer (CAC) in mice. Appl. Microbiol. Biotechnol. 104: 5915-5928.   DOI
43 Hill CJ, Lynch DB, Murphy K, Ulaszewska M, Jeffery IB, O'Shea CA, et al. 2017. Evolution of gut microbiota composition from birth to 24 weeks in the INFANTMET Cohort. Microbiome 5: 4.   DOI
44 Rezk BM, Haenen GR, van der Vijgh WJ, Bast A. 2002. The antioxidant activity of phloretin: the disclosure of a new antioxidant pharmacophore in flavonoids. Biochem. Biophys. Res. Commun. 295: 9-13.   DOI
45 Sender R, Fuchs S, Milo R. 2016. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164: 337-340.   DOI